Biologics Working Party documents

Amended Biologics Working Party Vaccines Quality Operational Expert Group (BV-OEG) Influenza Meeting: EU recommendations for the seasonal influenza vaccine composition for the season 2025/2026

Reference Number: EMADOC-628903358-119194

English (EN) (136.87 KB - PDF)

First published: 01/04/2025Last updated: 09/04/2025

View

Amended Biologics Working Party (BWP) Ad hoc Influenza Working Group - EU recommendations for the seasonal influenza vaccine composition for the season 2023/2024

AdoptedReference Number: EMA/CHMP/BWP/126676/2023

English (EN) (192.21 KB - PDF)

First published: 03/04/2023Last updated: 20/04/2023

View

Amended Biologics Working Party (BWP) Ad hoc Influenza Working Group - EU recommendations for the seasonal influenza vaccine composition for the season 2022/2023

Reference Number: EMA/CHMP/BWP/116744/2022

English (EN) (175.47 KB - PDF)

First published: 29/03/2022Last updated: 30/03/2022

View

Biologics Working Party (BWP) Ad hoc Influenza Working Group - Amended European Union recommendations for the seasonal influenza vaccine composition for the season 2021/2022

AdoptedReference Number: EMA/CHMP/BWP/80561/2021

English (EN) (176.61 KB - PDF)

First published: 30/03/2021Last updated: 28/06/2021

View

Biologics Working Party (BWP) Ad hoc Influenza Working Group - Amended European Union recommendations for the seasonal influenza vaccine composition for the season 2020/2021

AdoptedReference Number: EMA/CHMP/BWP/134670/2020Summary:

EU recommendations for the seasonal influenza vaccine composition for the season 2020/2021

English (EN) (205.91 KB - PDF)

First published: 01/04/2020Last updated: 15/05/2020

View

Biologics Working Party (BWP) Ad hoc Influenza Working Group - Amended European Union recommendations for the seasonal influenza vaccine composition for the season 2019/2020

AdoptedReference Number: EMA/CHMP/BWP/266098/2019

English (EN) (199.83 KB - PDF)

First published: 01/04/2019Last updated: 20/05/2019

View

Biologics Working Party (BWP) ad-hoc influenza working group: Amended European Union recommendations for the seasonal influenza vaccine composition for the season 2018/2019

Reference Number: EMA/CHMP/BWP/209019/2018

English (EN) (93.84 KB - PDF)

First published: 26/03/2018Last updated: 30/04/2018

View

Biologics Working Party report on viral safety of plasma-derived and urine-derived medicinal products with respect to Zika virus

Reference Number: EMA/CHMP/BWP/596747/2016

English (EN) (115.31 KB - PDF)

First published: 21/09/2016Last updated: 21/09/2016

View

Biologics Working Party (BWP) Ad-hoc Influenza Working Group: Amended European Union recommendations for the seasonal influenza vaccine composition for the season 2017/2018

Reference Number: EMA/CHMP/BWP/216216/2017

English (EN) (83.23 KB - PDF)

First published: 24/03/2017Last updated: 12/04/2017

View

Biologics Working Party Ad-hoc Influenza Working Group: European Union recommendations for the seasonal influenza vaccine composition for the season 2016/2017

Reference Number: EMA/CHMP/BWP/165983/2016Summary:

Biologics Working Party Ad-hoc Influenza Working Group: European Union recommendations for the seasonal influenza vaccine composition for the season 2016/2017

English (EN) (106.94 KB - PDF)

First published: 04/04/2016Last updated: 04/04/2016

View

Biologics Working Party Ad-hoc Influenza Working Group: Amended European Union recommendations for the seasonal-influenza-vaccine composition for the season 2015 / 2016

Reference Number: EMA/CHMP/BWP/169555/2015

English (EN) (153.35 KB - PDF)

First published: 27/03/2015Last updated: 27/05/2015

View

Biologics Working Party Ad-hoc Influenza Working Group: European Union recommendations for the seasonal-influenza-vaccine composition for the season 2014 / 2015

Reference Number: EMA/CHMP/BWP/109993/2014

English (EN) (84.32 KB - PDF)

First published: 21/03/2014Last updated: 21/03/2014

View

CHMP/Biologics Working Party report to the CMDh on pancreatin-containing products

Reference Number: EMEA/CHMP/BWP/373049/2013Summary:

At the request of the CMDh, the Biologics Working Party (BWP) and the Committee for Medicinal Products for Human Use (CHMP) assessed the viral risk of pancreatin products and expressed their view on whether the SmPCs of these products should include a harmonised warning about their viral safety.

English (EN) (94.12 KB - PDF)

First published: 04/10/2013Last updated: 04/10/2013

View

Biologics Working Party Ad-hoc Influenza Working Group: Amended European Union recommendations for the seasonal-influenza-vaccine composition for the season 2013 / 2014

AdoptedReference Number: EMA/CHMP/BWP/116620/2013

English (EN) (92.22 KB - PDF)

First published: 16/03/2012Last updated: 02/04/2013

View

Biologics Working Party Ad-hoc Influenza Working Group: European Union recommendations for the seasonal-influenza-vaccine composition for the season 2011 / 2012

AdoptedReference Number: EMA/CHMP/BWP/156215/2011

English (EN) (65.24 KB - PDF)

First published: 17/03/2011Last updated: 17/03/2011

View

European Union recommendations for the seasonal-influenza-vaccine composition for the season 2010 / 2011

AdoptedReference Number: EMA/CHMP/BWP/107653/2010

English (EN) (65.29 KB - PDF)

First published: 18/03/2010Last updated: 18/03/2010

View

Report of plasma master file epidemiology workshop with industry

Reference Number: EMEA/CHMP/BWP/233408/2009

English (EN) (87.41 KB - PDF)

First published: 19/11/2009Last updated: 19/11/2009

View

Report: Expert workshop on Creutzfeldt-Jakob-disease risk and urine-derived medicinal products

Reference Number: EMEA/CHMP/BWP/472717/2009

English (EN) (135.72 KB - PDF)

First published: 23/07/2009Last updated: 23/07/2009

View

European Union recommendation for the emergent-novel-H1N1-influenza-vaccine composition - Revised to include strain IVR-153

AdoptedReference Number: EMEA/CHMP/BWP/340831/2009/Rev 1

English (EN) (22.93 KB - PDF)

First published: 10/06/2009Last updated: 10/06/2009

View

European Union recommendations for the seasonal-influenza-vaccine composition for the season 2009 / 2010

AdoptedReference Number: EMEA/CHMP/BWP/133895/2009/Rev 1

English (EN) (28.44 KB - PDF)

First published: 23/04/2009Last updated: 23/04/2009

View

European Union recommendation for the seasonal-influenza-vaccine composition for the season 2008 / 2009

AdoptedReference Number: EMEA/CHMP/BWP/133836/2008

English (EN) (26.4 KB - PDF)

First published: 19/03/2008Last updated: 19/03/2008

View

Biologics Working Party report to the CHMP: Beta-interferons and neutralising antibodies (in multiple sclerosis)

Reference Number: EMEA/CHMP/BWP/580136/2007

English (EN) (37.56 KB - PDF)

First published: 13/02/2008Last updated: 13/02/2008

View

Report: Biologics Working Party, Process Analytical Technologies Group and industry

Reference Number: EMEA/CHMP/BWP/185370/2007

English (EN) (40.37 KB - PDF)

First published: 16/07/2007Last updated: 16/07/2007

View

European Union recommendations for the influenza-vaccine composition for the season 2007 / 2008

AdoptedReference Number: EMEA/CHMP/BWP/108182/07

English (EN) (34.66 KB - PDF)

First published: 19/03/2007Last updated: 19/03/2007

View

European Union recommendations for the influenza-vaccine composition for the season 2006 / 2007

AdoptedReference Number: EMEA/CHMP/BWP/123643/2006

English (EN) (38.03 KB - PDF)

First published: 29/05/2006Last updated: 29/05/2006

View

European Union recommendations for the influenza-vaccine composition for the season 2005 / 2006

AdoptedReference Number: EMEA/BWP/111233/05

English (EN) (25.11 KB - PDF)

First published: 30/03/2005Last updated: 30/03/2005

View

First cases of bovine spongiform encephalopathy in the United States (USA) and Canada: Risk assessment of ruminant materials originating from the USA and Canada

AdoptedReference Number: EMEA/CHMP/BWP/27/04Legal effective date: 01/07/2004

English (EN) (173.36 KB - PDF)

First published: 21/07/2004Last updated: 21/07/2004

View

European Union recommendations for the influenza-vaccine composition for the season 2004 / 2005

AdoptedReference Number: EMEA/BWP/1104/04

English (EN) (112.37 KB - PDF)

First published: 21/07/2004Last updated: 21/07/2004

View

CPMP position statement on West Nile virus and plasma-derived medicinal products

AdoptedReference Number: EMEA/CPMP/BWP/3752/03/adoptedLegal effective date: 25/07/2003

English (EN) (134.87 KB - PDF)

First published: 25/07/2003Last updated: 25/07/2003

View

Final European Union recommendation for influenza-vaccine composition for the season 2003 / 2004

AdoptedReference Number: CPMP/BWP/6011/03

English (EN) (110.33 KB - PDF)

First published: 19/03/2002Last updated: 19/03/2002

View

CPMP position statement - non-remunerated and remunerated donors: safety and suply of plasma-derived medicinal products

AdoptedReference Number: EMEA/CPMP/BWP/1818/02 Final

English (EN) (116.84 KB - PDF)

First published: 30/05/2002Last updated: 30/05/2002

View

European Medicines Agency workshop on the plasma master file, 10-11 October 2001: Summary report

Reference Number: EMEA/CPMP/BWP/173/02

English (EN) (230.52 KB - PDF)

First published: 18/12/2002Last updated: 18/12/2002

View

Final European Union recommendations for the influenza-vaccine composition for the season 2002 / 2003

AdoptedReference Number: CPMP/BWP/852/02

English (EN) (104.27 KB - PDF)

First published: 21/03/2002Last updated: 21/03/2002

View

European Medicines Agency workshop on viral safety of plasma-derived medicinal products with particular focus on non-enveloped viruses, 13 September 2000: Summary report

AdoptedReference Number: CPMP/BWP/BPWG/4080/00

English (EN) (174.45 KB - PDF)

First published: 28/03/2001Last updated: 28/03/2001

View

European Medicines Agency expert meeting on human transmissible spongiform encephalopathies and medicinal products derived from human blood and plasma, 1 December 2000: Summary report

Reference Number: EMEA/CPMP/BWP/450/01

English (EN) (176.07 KB - PDF)

First published: 28/03/2001Last updated: 28/03/2001

View

Questions and answers on bovine spongiform encephalopathies (BSE) and vaccines - First version

AdoptedReference Number: EMEA/CPMP/BWP/819/01Legal effective date: 23/04/2001

English (EN) (59.49 KB - PDF)

First published: 24/04/2001Last updated: 24/04/2001

View

Topics

Biologicals

Related content

Topics

Share this page